Sergi Clavé
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 17
- Lung Cancer Diagnosis and Treatment 2
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Álvaro Taus (16 shared papers)Marta Salido (16 shared papers)Edurne Arriola (18 shared papers)Joan Albanell (11 shared papers)Lara Pijuan (13 shared papers)Silvia Gra Menendez (6 shared papers)Marta Lorenzo (5 shared papers)David Casadevall (6 shared papers)
- Journals
- Journal of Thoracic Oncology (5 papers)Annals of Oncology (4 papers)Clinical Lung Cancer (3 papers)Lung Cancer (2 papers)Oncotarget (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Sergi Clavé
29 papers receiving 446 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 115
- Oncology 200
- Pulmonary and Respiratory Medicine 221
- Hepatology 20
- Obstetrics and Gynecology 14
Countries citing papers authored by Sergi Clavé
This map shows the geographic impact of Sergi Clavé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergi Clavé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergi Clavé more than expected).
Fields of papers citing papers by Sergi Clavé
This network shows the impact of papers produced by Sergi Clavé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergi Clavé. The network helps show where Sergi Clavé may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergi Clavé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 76 | |
| 2 | 2015 | 56 | |
| 3 | 2018 | 47 | |
| 4 | 2019 | 43 | |
| 5 | 2019 | 35 | |
| 6 | 2017 | 32 | |
| 7 | 2016 | 23 | |
| 8 | 2014 | 23 | |
| 9 | 2014 | 23 | |
| 10 | 2015 | 17 | |
| 11 | 2019 | 14 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2023 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2020 | 2 |
About Sergi Clavé
Sergi Clavé is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 31 papers that have together received 452 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers), RNA modifications and cancer (4 papers), Prenatal Substance Exposure Effects (3 papers), Birth, Development, and Health (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (115 citations), Oncology (200 citations), Pulmonary and Respiratory Medicine (221 citations), Hepatology (20 citations) and Obstetrics and Gynecology (14 citations). Sergi Clavé has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Álvaro Taus, Marta Salido, Edurne Arriola, Joan Albanell, Lara Pijuan, Silvia Gra Menendez, Marta Lorenzo, David Casadevall, Pedro Rocha and Max Hardy-Werbin. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Clinical Lung Cancer, Lung Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.